PRICE T ROWE ASSOCIATES INC /MD/ - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 157 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$313
+40.4%
74,169
+3.3%
0.00%
Q2 2023$223
+696.4%
71,808
+262.3%
0.00%
Q1 2023$28
-20.0%
19,819
+12.5%
0.00%
Q4 2022$35
-99.9%
17,616
+3.1%
0.00%
Q3 2022$35,000
-99.9%
17,091
-99.8%
0.00%
-100.0%
Q3 2019$32,722,000
-75.6%
11,283,585
-39.6%
0.01%
-73.7%
Q2 2019$133,836,000
-52.4%
18,666,125
-6.0%
0.02%
-53.7%
Q1 2019$281,436,000
+6.0%
19,861,418
+1.2%
0.04%
-8.9%
Q4 2018$265,482,000
+8.1%
19,621,696
+77.2%
0.04%
+25.0%
Q3 2018$245,654,000
+34402.0%
11,070,504
+25401.0%
0.04%
Q2 2018$712,00043,4120.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$102,442,0009.84%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$77,176,0001.36%
Sivik Global Healthcare LLC 600,000$2,856,0000.95%
THB ASSET MANAGEMENT 651,150$3,099,0000.90%
Eversept Partners, LP 886,587$4,220,1540.58%
Spark Investment Management LLC 30,100$143,0000.52%
GLOBEFLEX CAPITAL L P 240,680$1,146,0000.29%
Alambic Investment Management, L.P. 19,493$93,0000.23%
GSA CAPITAL PARTNERS LLP 49,901$238,0000.13%
C M BIDWELL & ASSOCIATES LTD 29,550$141,0000.13%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders